click below
click below
Normal Size Small Size show me how
Oncology – ABIM
Non-small cell and small cell lung cancer
Question | Answer |
---|---|
What is the treatment for non-small cell lung cancer if tumor is greater than 2 cm away from the carina and there is no lymph node involvement? | Surgery and chemo |
What is the treatment for non-small cell lung cancer if the tumor is greater than 2 cm away from the carina and there is ipsilateral lymph node involvement? | Surgery and chemo |
In non-small cell lung cancer, which patients get surgery and chemo only? | Patients whose tumor is greater than 2 cm away from the carina and disease that does not cross the midline. |
What is the treatment in non-small cell lung carcinoma when the tumor is less than 2 cm away from the carina and there is ipsilateral lymph node involvement? | Surgery, chemo, radiation |
What is the treatment and non-small cell lung carcinoma when the tumor is less than 2 cm away from the carina and there is contralateral lymph node involvement? | Chemo and radiation |
What automatically takes surgery out of the treatment option for non-small cell lung carcinoma? | involvement of a contralateral or right supra-clavicular lymph node |
What is the treatment for non-small cell lung carcinoma when there is right supra clavicular node involvement? | Chemotherapy – erlotinib and gefitinib |
What is the treatment for non-small cell lung carcinoma when there is a pleural effusion composed of malignant cells? | Chemotherapy – erlotinib and gefitinib |
In small cell lung carcinoma, what is the treatment when one hemi thorax is involved? | Chemo, brain radiation, lung radiation |
In small cell lung carcinoma, what is the treatment when there is extensive disease? | Chemo and brain radiation |
What is the treatment for small cell lung carcinoma in an elderly person? | Chemo and brain radiation |
What is the mechanism of erlotinib? | inhibits overall epidermal growth factor receptor (HER1/EGFR) - tyrosine kinase activity --> cell death |
What should happen after the resection of a non-small cell tumor? | Check for EGFR/HER2 mutation to decide whether we can use EGFR tyrosine kinase inhibitor |
What to treat with if a patient has progression of non-small cell lung carcinoma despite cisplatin-based chemotherapy? | nivolumab, a programmed cell death 1 (PD-1) inhibitor The PD-1 gene downregulates the immune system by preventing T-cell activation; it is thought that many malignancies escape immune surveillance via a PD-1–related mechanism. |
What does silicosis put you at risk for? | Lung cancer and tuberculosis |